Entreprise · 08/09/20091 min de lecture
2009 Parenteral Drug Association and Food and Drug Administration Joint Regulatory Conference
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) in co-sponsorship with the Parenteral Drug Association (PDA), is announcing a conference entitled "Securing the Future of Medical Product Quality: A 2020 Vision." The workshop helps to achieve objectives set forth in the FDA Modernization Act of 1997, which include working closely with stakeholders and maximizing the availability and clarity of information to stakeholders and the public. Date and Time: The conference will be held on Monday, September 14, 2009 from 8 a.m. to 6 p.m.; Tuesday, September 15, 2009 from 7:15 a.m. to 5:45 p.m.; and Wednesday, September 16 from 7:15 a.m. to 1:15 p.m. Location: The public workshop will be held at the Renaissance Hotel, 999 9th St., Washington, D.C., 20001; 1-202-898-9000; FAX: 1- 202-289-0947. Contact: Regarding the conference: Wanda Neal, Parenteral Drug Association, PDA Global Headquarters, Bethesda Towers, 4350 East-West Hwy., suite 200, Bethesda, MD 20814. Regarding this document: Ken Nolan, Office of External Relations, Food and Drug Administration, 5600 Fishers Lane, rm. 15-05, Rockville, MD 20857, 301-827-3376. Registration: You are encouraged to register at your earliest convenience. The PDA re